Raquel E Gur1, Mary March2, Monica E Calkins2, Lauren Weittenhiller2, Daniel H Wolf2, Bruce I Turetsky2, Ruben C Gur2. 1. Department of Psychiatry, Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, 10 Gates, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: raquel@upenn.edu. 2. Department of Psychiatry, Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, 10 Gates, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Abstract
BACKGROUND: Negative symptoms in schizophrenia are related to impaired functioning. The presence of negative symptoms in early phases of psychosis in individuals at clinical risk is receiving increased attention. METHODS: We evaluated comprehensively a sample of 92 young people (age range 15-25) applying the Clinical Assessment Interview for Negative Symptoms (CAINS), adapted for youth. Individuals at clinical high risk (CHR, n=29) were compared to individuals with schizophrenia (SZ, n=31) and normal controls (NC, n=32). In addition to the CAINS, participants were assessed with the Structured Interview for Prodromal Syndromes (SIPS), enabling examination of the relations among scales, as well as the Penn Computerized Neurocognitive Battery (CNB), to examine association with cognitive performance, and the Global Assessment of Function (GAF) to assess overall functioning. RESULTS: The CHR group was intermediate to SZ and NC on nearly all clinical measures. Negative symptoms on the CAINS correlated better with negative than with other symptoms on the SIPS and were associated with neurocognitive deficits and poorer functioning. CONCLUSIONS: This study illustrates the feasibility of in-depth evaluation of negative symptoms in youth and indicates that these symptoms are present already in the at-risk state and relate to impaired cognition and functioning.
BACKGROUND: Negative symptoms in schizophrenia are related to impaired functioning. The presence of negative symptoms in early phases of psychosis in individuals at clinical risk is receiving increased attention. METHODS: We evaluated comprehensively a sample of 92 young people (age range 15-25) applying the Clinical Assessment Interview for Negative Symptoms (CAINS), adapted for youth. Individuals at clinical high risk (CHR, n=29) were compared to individuals with schizophrenia (SZ, n=31) and normal controls (NC, n=32). In addition to the CAINS, participants were assessed with the Structured Interview for Prodromal Syndromes (SIPS), enabling examination of the relations among scales, as well as the Penn Computerized Neurocognitive Battery (CNB), to examine association with cognitive performance, and the Global Assessment of Function (GAF) to assess overall functioning. RESULTS: The CHR group was intermediate to SZ and NC on nearly all clinical measures. Negative symptoms on the CAINS correlated better with negative than with other symptoms on the SIPS and were associated with neurocognitive deficits and poorer functioning. CONCLUSIONS: This study illustrates the feasibility of in-depth evaluation of negative symptoms in youth and indicates that these symptoms are present already in the at-risk state and relate to impaired cognition and functioning.
Authors: D H Nieman; E Velthorst; H E Becker; L de Haan; P M Dingemans; D H Linszen; M Birchwood; P Patterson; R K R Salokangas; M Heinimaa; A Heinz; G Juckel; H G von Reventlow; A Morrison; F Schultze-Lutter; J Klosterkötter; S Ruhrmann Journal: Acta Psychiatr Scand Date: 2012-07-07 Impact factor: 6.392
Authors: Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: Monica E Calkins; Tyler M Moore; Kathleen R Merikangas; Marcy Burstein; Theodore D Satterthwaite; Warren B Bilker; Kosha Ruparel; Rosetta Chiavacci; Daniel H Wolf; Frank Mentch; Haijun Qiu; John J Connolly; Patrick A Sleiman; Hakon Hakonarson; Ruben C Gur; Raquel E Gur Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548
Authors: Christian G Kohler; Jan A Richard; Colleen M Brensinger; Karin E Borgmann-Winter; Catherine G Conroy; Paul J Moberg; Ruben C Gur; Raquel E Gur; Monica E Calkins Journal: Psychiatry Res Date: 2014-01-23 Impact factor: 3.222
Authors: Kelly A Allott; Miriam R Schäfer; Andrew Thompson; Barnaby Nelson; Sarah Bendall; Cali F Bartholomeusz; Hok Pan Yuen; Patrick D McGorry; Monika Schlögelhofer; Andreas Bechdolf; G Paul Amminger Journal: Schizophr Res Date: 2014-02-16 Impact factor: 4.939
Authors: Ruben C Gur; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Warren B Bilker; Tyler M Moore; Adam P Savitt; Hakon Hakonarson; Raquel E Gur Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal Journal: Schizophr Res Date: 2020-06-07 Impact factor: 4.939
Authors: David R Roalf; Megan Quarmley; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Mark A Elliott; Tyler M Moore; Ruben C Gur; Raquel E Gur; Paul J Moberg; Bruce I Turetsky Journal: Schizophr Bull Date: 2017-05-01 Impact factor: 9.306
Authors: Teresa Vargas; Hannah Snyder; Marie Banich; Rae Newberry; Stewart A Shankman; Gregory P Strauss; Vijay Anand Mittal Journal: Schizophr Res Date: 2018-06-20 Impact factor: 4.939
Authors: S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel Journal: Eur Psychiatry Date: 2021-02-18 Impact factor: 5.361